Biohouse

Home
Israel
Jerusalem
Biohouse

BIOHOUSE, a medical technology stakeholder community, combines strategic location, professional serv

06/05/2026

IP strategy isn’t legal hygiene — it’s business strategy.

Yesterday we hosted a CEO-focused session at BIOHOUSE on how to treat IP as a core asset — not a checkbox and not a “nice to have.”

Key messages that resonated strongly:

Your IP strategy belongs at the heart of your business plan. In many cases, the plan should be derived from the IP strategy — because it shapes what you can defend, partner on, license, and scale.
Protection isn’t a one-time event. IP is dynamic: it requires ongoing monitoring and continuous alignment with product evolution, publications, partnerships, and financing milestones.
The goal isn’t “more filings.” The goal is clarity and leverage — building a defensible position that supports growth.

Huge thanks to Morag-Sela (Partner & Head of Life Sciences) and the team at Reinhold Cohn for a sharp, practical session and an excellent discussion with our community.

📸 Sharing a few moments from yesterday below.

28/04/2026

Warrior Spirit. Startup Spirit.

How to survive a long crisis without losing your core.

After a long period of war, prolonged uncertainty, and one of the hardest environments biotech startups have faced in recent years, many founders are operating under constant pressure. Teams are tired. Fundraising is slower. Global investors are more hesitant. And in many cases, survival itself has become the challenge.

Sources:
Protect runway — but protect your core:
Lou Shipley, Harvard Business Review — 5 Ways Startups Can Prepare for a Recession (2022)
Nitin Nohria et al., Harvard Business Review — Case Study: How Should a Start-Up Cut Its Burn Rate? (2023)

Communicate early, clearly, and consistently:
McKinsey — How to communicate effectively in times of uncertainty (2020) McKinsey — A leader’s guide to crisis communication during coronavirus (2020) McKinsey — Leadership in a crisis: How leaders can support their organizations during the COVID-19 crisis and recovery.

Build resilience into the system
McKinsey — Raising the resilience of your organization (2022)
McKinsey — What is psychological safety? (2023)
Harvard Business Review — High-Performing Teams Need Psychological Safety—Here’s How to Create It (2017)
BioPharma Dive — Biotech ‘megarounds’ hold steady as startups, VCs wait on IPOs (April 3, 2025)
BioPharma Dive — A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups (June 20, 2025)

21/04/2026

We Remember. We Rise. We Build.

As Israel moves from Memorial Day into Independence Day, we carry both sorrow and gratitude.

We remember the fallen, honor grieving families, and hold close the pain that so many still live with. In Israel, this transition is never simple. The sadness does not fade when the celebration begins. It stays with us.

And still, we rise.

After years of war, loss, and uncertainty, Israel’s independence feels more precious than ever. We honor those who defend it with courage — including the legendary Israeli Air Force — and we honor the remarkable resilience of Israel’s citizens, who continue to stand together, support one another, and keep moving forward.

At BIOHOUSE, we believe that choosing to build — to heal, to create, to innovate — is its own act of hope.

On this day, we remember.
We rise.
And we keep building.

From all of us at BIOHOUSE,
we wish Israel strength, unity, and better days ahead.

30/03/2026

Together Into Spring.

Sometimes, all we need is a small piece of sky to keep going.
This season arrives in heavy days. Many are carrying exhaustion, uncertainty, and the quiet weight of everything around us. And still, spring returns — gently reminding us that renewal begins even in fragile moments.

At BIOHOUSE, we hold close the belief that community matters most in times like these. In coming together, in continuing to create, in making space for meaningful work and human connection, there is strength.

May this season bring a little more light, a little more breath, and a renewed sense of hope!

חג אביב שמח

04/03/2026

Even in days like these, we choose to keep celebrating life!💜

This Purim at BIOHOUSE was a reminder of what community can do: a room full of founders, scientists, builders, and doers—showing up for each other with warmth, humor, and resilience.

Because innovation isn’t only about technology.
It’s also about spirit: the ability to keep moving, keep creating, and keep believing—together.

Thank you to everyone who joined, brought the energy, and made this moment feel light again.

26/01/2026

Reimbursement Reality Check — Make the Payer Be the Winner

Your product can be clinically brilliant and still go nowhere if the wrong party is asked to pay. In healthcare, value often lands in one pocket (payer), while the invoice lands in another (provider). That mismatch—misaligned incentives / “value leakage”—kills deals quietly.

Professional and academic literature:
Porter, M.E. “A Strategy for Health Care Reform—Toward a Value-Based System.” NEJM (2009).

Teisberg, E. et al. “Defining and Implementing Value-Based Health Care.” (2019, highly cited overview).

NCBI Bookshelf: Clinical Resource Management — Reimbursement Models & Alternative Payment Models (shared risk pools, bundled, pay-for-performance).

CMS: Medicare Shared Savings Program (ACOs) — canonical shared-savings structure.

McKinsey (2018): Seven characteristics of successful alternative payment models (incl. incentive alignment pitfalls).

18/01/2026

Hosting the next generation of the biotech ecosystem.

M.Sc. students from the Hebrew University diving into exploring how science becomes startups and innovation becomes impact.

From academia to impact — this is how the future of biotech is built.

05/01/2026

The “Kill List” for 2026: Win by Stopping the Wrong Work

Most startups don’t fail from a lack of ideas — they fail from too many initiatives competing for the same scarce resources: founder attention, team capacity, and runway. A “Stop-Doing List” isn’t a vibe. It’s strategy in action: choosing trade-offs and protecting focus.

Source:

Michael E. Porter (1996) — “What Is Strategy?”
Harvard Business Review

Jeffrey Pfeffer & Robert I. Sutton (2000) — The Knowing-Doing Gap

Greg McKeown (2014) — Essentialism: The Disciplined Pursuit of Less.

31/12/2025

Happy New Year 2026
Wishing you a year of bold science, meaningful partnerships, and breakthroughs that truly improve lives.

30/12/2025

Proud moment for our BIOHOUSE members.

Huge congrats to NeuroGenesis Bio Inc. and Tal Gilat on being selected as one of the five companies featured in “The Next Prescription: Billion Dollar Healthcare Returns” at the YPO Global Business Summit in Los Angeles.

What stands out here isn’t just the recognition — it’s the sign for the next era of healthcare is about restoring lives, not managing decline.

At BIOHOUSE, we’re proud to host and support teams like NeuroGenesis Bio Inc. as they turn bold science into real-world clinical impact — faster, sharper, and with the right ecosystem around them.

Nir Netzer Dr. Ibrahim Kassis ( د. ابراهيم قسيس )

https://www.linkedin.com/feed/update/urn:li:activity:7410344439694508032/

Address

Yshparo Mall Hadassah Medical Center
Jerusalem

Website

http://biohouse.co/

Alerts

Be the first to know and let us send you an email when Biohouse posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Biohouse:

Shortcuts

Want your business to be the top-listed Engineering Company in Jerusalem?